BFC Planning’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
BFC Planning's SBIO Position: Q3 2026 in Review
BFC Planning opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q3 2026: 40 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #2963 among its holdings. This is a return to the name: BFC Planning previously reported a position in SBIO as recently as Q3 2025.
BFC Planning first reported a position in SBIO in Q3 2024 and has held it in 6 quarters since. The position peaked at $9.7K in Q3 2025. 60 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.
- BFC Planning held 40 shares of ALPS Medical Breakthroughs ETF worth $2.33K as of Q3 2026.
- ALPS Medical Breakthroughs ETF was a new BFC Planning position in Q3 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2963 holding.
- BFC Planning first reported a position in ALPS Medical Breakthroughs ETF in Q3 2024 and has held it in 6 quarters since.
- BFC Planning's ALPS Medical Breakthroughs ETF position peaked at $9.7K in Q3 2025.
- 60 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.